News & Press

News

Boro Dropulic to Share Pivotal Insights at Advanced Therapies Week on January 21-22, 2025

January 20, 2025

Press Release

AmplifyBio and Vector BioMed Partner to Manufacture Plasmids and Share Capabilities that Enhance the Safety and Scalability of Lentiviral-based Gene Therapeutics

October 31, 2023

Press Release

Vector BioMed's CEO, Dr. Boro Dropulić, to Speak at the 8th CAR-TCR Summit

August 21, 2023

News

Vector BioMed Selected as Preferred Lentiviral Vector Manufacturing Partner for California Institute for Regenerative Medicine

August 4, 2023

Press Release

Vector BioMed Appoints Jakob Reiser, Ph.D., as Senior Director of Regulatory Affairs

April 11, 2023

News

New US CDMO launched to address viral vector supply bottleneck

February 1, 2023

News

Vector BioMed launches with $15M to produce backlogged CAR-T component

January 31, 2023

News

CDMO Startup Vector BioMed Launches to Fill Lentiviral Gap for Cell & Gene Therapies

January 31, 2023

News

Vector BioMed debuts as viral vector CDMO with $15M funding

January 31, 2023

News

A startup launches with plans to open up a gene and cell therapy bottleneck

January 31, 2023

Partner With Us

Talk to our team today to learn more about our Lentiviral vector manufacturing solutions. If you are an academic organization, ask for our academic pricing.